BLUE OAK PHARMACEUTICAL

Blue Oak is set on restoring hope for patients with brain disorders by ending decades of stagnation in the development of new neuropsychiatric drugs. We offer a validated solution to the 40-year problem of discovering and developing truly novel mechanisms-of-action drugs for brain disorders... As interest in mental health - and neuroscience and neuropsychiatry in particular - increase, Blue Oak is well-positioned to help patients and their families. We are developing a pipeline of research and clinical programs that treat major brain disorders, including bipolar depression, schizophrenia and geriatric psychosis. Our circuit-repair strategy has already proven to be fundamentally better than the past historical strategy of modulating single-drug targets... Blue Oak delivers a podium presentation at the Keystone Meeting on Phenotypic Drug Discovery describing a systems neurobiology approach to discovering the next generation of drugs for bipolar depression.

Also known as: Blue Oak, Blue Oak Pharma

Primary location: Concord United States